Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

Lineage Cell Therapeutics, Inc. (LCTX : AMX)

Sector: Healthcare

Close
(02-03-2026)
$1.76
Change
$0.22 (14.29%)
Volume 2,284,618
Open $1.55
Day Range $1.54 - $1.76
52 Week Low $0.37
52 Week High $2.09
Annual Yield -
Annual Dividend -
Last Dividend (11-29-2018) $0.00
Industry Sector Healthcare
Quoted Market Value $405,376,465
Shares Outstanding 230,327,537
Book Value per Share $17.60
Earnings per Share -$0.29
Period
Loading...
Loading...

Legend

Lineage Cell Therapeutics, Inc.

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
February 03, 2026 1.76
$0.22 (14.29%)
February 02, 2026 1.54
$0.06 (4.05%)
January 30, 2026 1.48
-$0.09 (-5.73%)
January 29, 2026 1.57
-$0.01 (-0.63%)
January 28, 2026 1.58
-$0.05 (-3.07%)
January 27, 2026 1.63
$0.04 (2.52%)
January 26, 2026 1.59
-$0.02 (-1.24%)
January 23, 2026 1.61
-$0.04 (-2.42%)
January 22, 2026 1.65
-$0.01 (-0.60%)
January 21, 2026 1.66
$0.01 (0.61%)
January 20, 2026 1.65
-$0.05 (-2.94%)
January 19, 2026 1.70
$0.00 (0.00%)
January 16, 2026 1.70
$0.05 (3.03%)
January 15, 2026 1.65
-$0.05 (-2.94%)
January 14, 2026 1.70
$0.03 (1.80%)
January 13, 2026 1.67
-$0.09 (-5.11%)
January 12, 2026 1.76
$0.05 (2.92%)
January 09, 2026 1.71
-$0.05 (-2.84%)
January 08, 2026 1.76
-$0.07 (-3.83%)
January 07, 2026 1.83
$0.13 (7.65%)
January 06, 2026 1.70
$0.01 (0.59%)
January 05, 2026 1.69
$0.05 (3.05%)
January 02, 2026 1.64
-$0.03 (-1.80%)
January 01, 2026 1.67
$0.00 (0.00%)
December 31, 2025 1.67
$0.07 (4.38%)
December 30, 2025 1.60
-$0.03 (-1.84%)
December 29, 2025 1.63
-$0.02 (-1.21%)
December 26, 2025 1.65
-$0.03 (-1.79%)
December 25, 2025 1.68
$0.00 (0.00%)
December 24, 2025 1.68
$0.02 (1.20%)

Funds holding this stock

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports